“Vijay, I would just say, as Bob said in his prepared remarks, excluding Nutrition, we expect high single digits for the kind of remainder of the businesses to your point.”

In context

“ys a role together with the inflation aspects that we're facing. So that's really the challenge. Vijay Kumar: That's helpful. And maybe one last one. With the second half base business guidance mid-single digit to high single digits, if I look at 2Q ex China and ex Nutrition, the base business did north of 7%, which is in line with the high single sort of trajectory that investors have baked in. The back half of mid-single to high single... Robert Ford: So like I said, I think we've got an opportunity here on the back half also. We've set a floor. And again, I'll just reiterate that this is where contemplating all these puts and takes that we've been discussing, we feel confident in that floor number. And we believe that there's opportunities here for upside to that. Scott Leinenweber: Vijay, I would just say, as Bob said in his prepared remarks, excluding Nutrition, we expect high single digits for the kind of remainder of the businesses to your point. So the math you're doing there is right. Vijay Kumar: That's helpful, Scott. So the guide is assuming some impact here in the back half. That's helpful. Operator: And our next question will come from Travis Steed from Bank of America. Travis Steed: Can you hear me okay? Robert Ford: Yes. Travis Steed: Great. Just wanted to ask a couple more on the margin puts and takes, and I know these are related to Robbie's question. You mentioned a lot of like onetime costs in Nutrition with contracts on top of inflation and FX. So just wanted to think about the commitment and ability to grow operating margin off this year's base margins. If the macro environment just remains stable, I assume most of those Nutrition and onetime investments go away later this year as Nutrition ramps back up. Bu”